Allegations of widespread fraud raise questions about the safety of generic drugs made overseas
It is something we've all heard before: Generic drugs are the same as brand-name drugs. They contain the same active ingredients and their manufacturers are supposed to prove they work the same way as the brand-name counterparts. Many of those generics come from abroad, though, with 80 percent of active ingredients and 40 percent...
High blood pressure is billion-dollar target for device makers
Pharmacies are chock-full of prescription drugs to treat high blood pressure, and so are patients’ medicine cabinets. They can work well to keep blood pressure down if taken as directed, which most patients do not do.
Read More
FDA allows sale of certain blood pressure drugs amid shortage
(Reuters) - The U.S. Food and Drug Administration on Wednesday said it will temporarily allow certain manufacturers to sell blood pressure medications containing specified levels of a probable cancer-causing impurity in order to maintain adequate supplies of the drug.
Read More
Eli Lilly Will Sell Half-Price Version of Humalog, Its Popular Insulin
The drugmaker Eli Lilly will begin selling a cheaper version of its most popular insulin, Humalog, in an effort to head off criticism about the rising costs of prescription drugs, the company said Monday.
Lilly will begin selling an “authorized generic” of Humalog 100 for...
Big Pharma Boosts Drug Prices As Supplies Run Low, Study Reveals
Federal lawmakers have been griping about drug pricing for years, led most recently by President Donald Trump, who famously declared even before he was elected that the industry is “getting away with murder.” A new study could very well fuel those complaints.
Researchers at the University of Pittsburgh and Harvard Medical School scoured the U.S....
The Health 202: Congress reaches deal on major opioids’ package
Congress could send its sweeping opioids' package to President Trump by week's end after lawmakers reached an agreement late Tuesday night on a final bill to address the nation's public health crisis.
Several issues held up negotiations, but the biggest controversy had nothing to do with opioids at all.
News broke last week that...
Does Big Pharma Hike Prices When Meds Are in Short Supply?
TUESDAY, Sept. 18, 2018 (HealthDay News) -- Pharmaceutical companies appear to be engaging in price gouging during drug shortages, with costs rising at double the normal rate when medications are in limited supply, a new study claims.
Prices can be expected to rise about 20 percent for drugs facing a shortage, but only about 9...
FDA Repays Industry by Rushing Risky Drugs to Market
Nuplazid, a drug for hallucinations and delusions associated with Parkinson’s disease, failed two clinical trials. In a third trial, under a revised standard for measuring its effect, it showed minimal benefit. Overall, more patients died or had serious side effects on Nuplazid than after receiving no treatment.
Patients on Uloric, a gout drug, suffered more...
Urban-rural divide exacerbates opioid crisis, despite prescription drop
The number of opioid prescriptions written in the United States has declined in recent years, according to newly released federal data, but the number of people who have fallen victim to fatal overdoses from prescription painkillers or heroin continues to rise.
The problem is especially acute in
Court upholds $28M judgement against cigarette company
A federal appeals court has upheld a $28 million judgment against cigarette maker R.J. Reynolds in a lawsuit filed by a Connecticut smoker who got cancer.
A three-judge panel of the 2nd US Circuit Court of Appeals in New York also ruled Friday that the case will be sent back to the trial court to...
